Josh Gottheimer disclosed buy in Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)
Josh Gottheimer disclosed buy activity in Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX).
Signal
Congress Trade
Action
Buy
Capital
$1,001 - $15,000
Why it matters
Congress disclosures can highlight policy-adjacent trading activity. This card is generated from canonical action facts, not request-time scraping.